12.2 Quality Improvement, HEDIS & CMS Star Ratings

Quality Improvement, HEDIS & CMS Star Ratings

Executive Summary: The transition from volume-based fee-for-service medicine to value-based healthcare delivery has elevated quality improvement science to a core competency for ambulatory care pharmacists. Regulatory and accreditation organizations—including the National Committee for Quality Assurance (NCQA), the Pharmacy Quality Alliance (PQA), and the Centers for Medicare & Medicaid Services (CMS)—utilize standardized quality metrics to assess health plan performance, clinician quality, and clinical outcomes. Clinical pharmacists directly influence HEDIS measures, CMS Star Ratings (especially 3x weighted adherence measures), and MIPS scoring by closing clinical gaps in care, optimizing guideline-directed medical therapies, and deploying systematic Continuous Quality Improvement (CQI) methodologies (PDSA cycles, Lean Six Sigma, RCA, Ishikawa diagrams, and Pareto analysis).

1. Quality Measurement Organizations: NCQA, PQA & CMS

Understanding the landscape of healthcare quality requires distinguishing the primary standard-setting, accreditation, and regulatory organizations:

                               HEALTHCARE QUALITY ARCHITECTURE
+-----------------------------------------------------------------------------------------+
|                                 NATIONAL QUALITY ORGANIZATIONS                          |
+-----------------------+---------------------------------+-------------------------------+
| NCQA                  | PQA                             | CMS                           |
| (National Committee   | (Pharmacy Quality Alliance)     | (Centers for Medicare &       |
| for Quality Assurance)|                                 |  Medicaid Services)           |
+-----------------------+---------------------------------+-------------------------------+
| * Develops HEDIS      | * Develops medication-focused   | * Administers Medicare Part C |
| * Accredits health    |   quality measures              |   and Part D Star Ratings     |
|   plans, PCMHs, ACOs  | * Measures adopted by CMS,      | * Enforces MACRA / MIPS       |
| * Focuses on clinical |   NCQA, and commercial payers   |   reimbursement adjustments   |
|   process & outcomes  | * Focus: Adherence, Safety, CMM | * Distributes Quality Bonuses |
+-----------------------+---------------------------------+-------------------------------+

1. National Committee for Quality Assurance (NCQA)

• A private, non-profit organization dedicated to improving healthcare quality through the accreditation of health maintenance organizations (HMOs), preferred provider organizations (PPOs), and Patient-Centered Medical Homes (PCMHs).
• HEDIS (Healthcare Effectiveness Data and Information Set): The gold standard performance measurement tool used by over 90% of America's health plans to measure performance on important dimensions of care and service across 6 domains (effectiveness of care, access/availability of care, experience of care, utilization and risk-adjusted utilization, health plan descriptive information, and measures reported using electronic clinical data systems).

2. Pharmacy Quality Alliance (PQA)

• A multi-stakeholder, consensus-based national organization dedicated to improving medication safety, adherence, and appropriate use.
• PQA develops and validates scientifically rigorous medication-use quality measures that are subsequently endorsed and adopted by CMS in the Medicare Part D Star Ratings and by NCQA in HEDIS.

3. Centers for Medicare & Medicaid Services (CMS)

• The federal agency administering Medicare, Medicaid, and the Children's Health Insurance Program (CHIP).
• CMS operationalizes quality measurement through the Medicare Part C (Medicare Advantage) & Part D (Prescription Drug Plan) Star Rating System and the Quality Payment Program (QPP) under MACRA.

2. CMS Medicare Part C & D Star Ratings System

The CMS Star Rating system scores Medicare Advantage (Part C) and standalone Prescription Drug Plans (Part D) on a 1 to 5-star scale (1 = Poor, 3 = Average, 5 = Excellent). Ratings are published annually on the Medicare Plan Finder to guide beneficiary plan selection and determine federal financial incentives.

Financial & Operational Stakes of Star Ratings

• Quality Bonus Payments (QBP): Medicare Advantage plans that achieve $\ge 4.0$ Stars receive a substantial 5% quality bonus payment added to their monthly per-member benchmark, enabling plans to offer enhanced supplemental benefits (e.g., dental, vision, $0 copays) that attract greater enrollment.
• Year-Round Open Enrollment: Plans achieving a 5-Star Rating earn the coveted 5-star special enrollment period (SEP), allowing beneficiaries to switch into the 5-star plan at any time throughout the calendar year, providing a massive competitive market advantage.
• Low-Performing Icon (LPI): Plans scoring $<3.0$ stars for three consecutive years receive a public warning icon on Medicare Plan Finder and face potential contract termination by CMS.

Measure Categories & Weighting Hierarchy

CMS assigns different statistical weight multipliers to measures based on their clinical significance:

• Process Measures: Weight = 1x (e.g., plan administration, routine screenings)
• Patient Experience / Complaints / Access Measures: Weight = 2x or 4x (CAHPS surveys, disenrollment rates)
• Clinical Outcomes & Patient Safety / Adherence Measures: Weight = 3x (Heavily driven by clinical pharmacist interventions!)

Core Pharmacist-Impacted CMS Star & HEDIS Measures

Mathematics of Adherence: Proportion of Days Covered (PDC)

CMS and PQA utilize the Proportion of Days Covered (PDC) rather than Medication Possession Ratio (MPR) because PDC adjusts for overlapping fills and provides a more conservative, clinically accurate measurement of longitudinal medication availability.

$\text{PDC} = \left( \frac{\text{Total Non-Overlapping Days Covered by Medication in Measurement Period}}{\text{Total Days in Measurement Period (from Index Prescription Date to Period End)}} \right) \times 100\%$

• Threshold for Adherence: A patient is classified as adherent if their $\text{PDC} \ge 80%$ (or $\ge 90%$ for certain antiretroviral regimens).
• Index Date: The date of the first prescription fill of the target drug class in the measurement year.
• Adjustment for Overlapping Fills: If a patient refills a 30-day supply on Day 25, the remaining 5 days are pushed forward to begin on Day 31 rather than double-counting coverage on Days 25–30.

3. Value-Based Payment Models: MACRA, MIPS & APMs

The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) repealed the Sustainable Growth Rate (SGR) formula and established the Quality Payment Program (QPP), fundamentally linking physician and clinic Medicare Part B reimbursement to quality performance and cost efficiency through two tracks:

                              MACRA QUALITY PAYMENT PROGRAM (QPP)
+-----------------------------------------------------------------------------------------+
|                                 TWO REIMBURSEMENT TRACKS                                |
+---------------------------------------------+-------------------------------------------+
| Track 1: MIPS                               | Track 2: Advanced APMs                    |
| (Merit-based Incentive Payment System)      | (Alternative Payment Models)              |
+---------------------------------------------+-------------------------------------------+
| * Evaluates individual clinicians & clinics | * Clinicians participate in risk-bearing  |
| * Four Performance Categories:              |   entities (e.g., Medicare Shared Savings |
|   1. Quality (30%)                          |   ACOs, Bundled Payments)                 |
|   2. Cost / Resource Use (30%)              | * Exempt from MIPS reporting              |
|   3. Promoting Interoperability (25%)       | * Eligible for 3.5% to 5% lump-sum bonus  |
|   4. Improvement Activities (15%)           |   and shared savings distributions        |
| * Performance drives upward / downward      | * Pharmacists optimize total cost of care |
|   Medicare Part B fee-for-service MIPS      |   by preventing ER visits & readmissions  |
|   reimbursement adjustments (up to ±9%)     |                                           |
+---------------------------------------------+-------------------------------------------+

Clinical Pharmacist Impact Across MIPS Categories

1. Quality Category (30%): Pharmacists directly improve clinical quality measures (CQMs) by titrating BP to $<130/80\text{ mmHg}$, lowering HbA1c $<8.0%$, initiating statins in ASCVD/diabetes, and optimizing anticoagulation for atrial fibrillation.
2. Cost Category (30%): Pharmacists reduce total per capita cost of care (TPCC) and Medicare spending per beneficiary (MSPB) by deprescribing high-risk anticholinergic medications, substituting high-cost non-formulary agents with cost-effective generics/biosimilars, and preventing acute hospitalizations.
3. Promoting Interoperability (25%): Pharmacists drive e-prescribing adherence, bidirectional electronic medication reconciliation at care transitions, and patient engagement via the patient portal.
4. Improvement Activities (15%): Establishing pharmacist-led CMM clinics, expanding chronic care management (CCM) access for underserved populations, and integrating telehealth qualify directly for high-weight clinical practice improvement activity credits.

4. Quality Improvement Methodologies & Analytical Tools

Executing clinical quality advancement requires mastering structured, evidence-based quality improvement (QI) methodologies and visual problem-solving tools.

1. The Plan-Do-Study-Act (PDSA) Cycle

Derived from the Deming/Shewhart cycle, the PDSA cycle is an iterative, four-stage scientific model for testing and implementing practice changes on a rapid, small scale before full institutional deployment:

• Plan: Identify the specific problem, establish a SMART aim statement (Specific, Measurable, Actionable, Relevant, Time-bound), analyze root causes using baseline data, formulate an evidence-based change hypothesis, and develop an actionable test plan.
• Do: Execute the planned intervention on a limited, small scale (e.g., testing a new pharmacist-led statin prescribing protocol with a single physician panel over a 4-week pilot). Document unexpected observations, protocol deviations, and workflow barriers.
• Study: Compare post-intervention data against baseline metrics and predicted targets. Evaluate process measures (e.g., number of patients contacted) and outcome measures (e.g., change in statin fill rates). Identify unintended consequences (e.g., provider alert fatigue, patient confusion).
• Act: Based on data analysis, determine whether to:
  • Adopt: Standardize and scale the intervention across the entire clinical practice.
  • Adapt: Modify specific components of the protocol (e.g., refining EHR screening criteria) and launch a second, iterative PDSA cycle.
  • Abandon: Cease the intervention if the test produced no benefit or caused clinical workflow disruption, pivoting to an alternative strategy.

2. Lean Six Sigma in Healthcare Operations

• Lean Methodology: Originating from the Toyota Production System, Lean focuses relentlessly on eliminating non-value-added waste (muda) to optimize workflow velocity. In healthcare, Lean targets the 8 Wastes (DOWNTIME):
  • Defects: Medication errors, wrong doses, incomplete prescription orders.
  • Overproduction: Ordering unnecessary laboratory tests, duplicate documentation.
  • Waiting: Patient waiting room delays, pharmacists waiting for physician chart co-signatures.
  • Non-utilized Talent: Pharmacists performing manual packaging instead of clinical CMM; nurses sorting paper charts.
  • Transportation: Unnecessary movement of physical charts, excessive specimen transport.
  • Inventory: Expired medication stock, excessive unused clinical supplies.
  • Motion: Clinicians navigating across 12 disjointed EHR tabs to locate a creatinine clearance.
  • Extra-processing: Redundant intake questionnaires, double-data entry across disconnected software.
• Six Sigma Methodology: Developed by Motorola, Six Sigma focuses on reducing process variation and eliminating defects. Operating at a true "Six Sigma level" equates to no more than 3.4 defects per million opportunities ($99.99966%$ defect-free). Six Sigma employs the structured DMAIC framework:
  • Define the clinical problem and customer/patient requirements.
  • Measure current baseline process performance.
  • Analyze data to identify root causes of defects and variation.
  • Improve the process by developing and piloting targeted solutions.
  • Control the improved process with standard operating procedures (SOPs) and dashboards to sustain gains.

3. Root Cause Analysis (RCA) & Visual Problem-Solving Tools

The 5 Whys Technique

An interrogative technique used to drill down through superficial symptoms to uncover the root defect by repeatedly asking "Why?" (typically five times) whenever a quality failure occurs.

Ishikawa (Fishbone / Cause-and-Effect) Diagram

A visual diagnostic tool that maps all potential contributors to a specific quality defect across six standardized thematic categories:

• People / Personnel: Inadequate staff training, provider lack of guideline awareness, patient health literacy barriers.
• Processes / Methods: Flawed intake workflows, lack of standardized titration protocols, absent refill synchronization.
• Policies: Restrictive health plan formularies, outdated institutional bylaws, lack of standing orders.
• Plant / Environment: Noisy workspace, lack of private consultation rooms for patient counseling.
• Equipment / Technology / Tools: Disconnected EHR systems, absent clinical decision support (CDS) alerts, inaccurate digital blood pressure cuffs.
• Materials / Supplies: Lack of translated patient education handouts, unavailable medication samples.

Pareto Analysis & The 80/20 Rule

Named after economist Vilfredo Pareto, the Pareto Principle states that roughly $80%$ of effects (defects/problems) arise from $20%$ of causes. In clinical quality management, a Pareto Chart plots the frequency of specific causes in descending bar graph order alongside a cumulative percentage line. This allows ambulatory care leaders to identify the "vital few" root causes that should receive $80%$ of resource allocation, rather than wasting capital on the "trivial many."

                               SAMPLE PARETO ANALYSIS: NON-ADHERENCE ROOT CAUSES
   100% +----------------------------------------------------------------------+ 100%
        | [=====]                                                        --*--| Cumulative %
    80% | [=====]       [=====]                                      --*--    | 80% Threshold
        | [=====]       [=====]                                  --*--        | (Vital Few)
    60% | [=====]       [=====]       [=====]                --*--            | 
        | [=====]       [=====]       [=====]            --*--                | 
    40% | [=====]       [=====]       [=====]        --*--                    | 
        | [=====]       [=====]       [=====]    --*--                        | 
    20% | [=====]       [=====]       [=====] [=====]  [=====]  [=====]       | 
        +---------------------------------------------------------------------+
          High Drug    Fear of Side   Forget-  Complex Refill   Transp-  Other
            Cost         Effects      fulness  Regimen Friction ortation
          (42.0%)        (26.5%)      (14.0%)   (8.5%)   (5.0%)   (4.0%)
          |---------------------------------|  |-----------------------------|
                   VITAL FEW (82.5%)               TRIVIAL MANY (17.5%)

4. Clinical Quality Dashboards & Gap-in-Care Outreach Workflows

Ambulatory care pharmacists utilize centralized population health registries and EHR quality dashboards to operationalize systematic gap-in-care closures:

• Registry Stratification: Querying electronic registries to extract patient lists failing quality metrics (e.g., active diabetes without statin on profile, PDC $<80%$, uncontrolled BP $>140/90\text{ mmHg}$, overdue HbA1c $>12$ months).
• High-Yield Outreach Interventions:
  • Refill Synchronization (Med Sync): Aligning all chronic maintenance medications to a single monthly pickup date.
  • 90-Day Supply Conversions: Transitioning 30-day fills to 90-day mail order or retail maintenance fills, which mathematically increases PDC by reducing monthly pharmacy trip friction.
  • Formulary & Co-Pay Optimization: Switching tier-3 brand agents to tier-1 generic therapeutic equivalents to eliminate financial abandonment.